Marché mondial de l'insomnie - Tendances et prévisions de l'industrie jusqu'en 2029

Analyse et perspectives du marché mondial de l'insomnie

Le marché de l'insomnie devrait connaître une croissance exponentielle au cours de la période de prévision 2022-2029. Data Bridge Market Research analyse le marché pour s'attendre à une croissance de 5,4 % au cours de la période de prévision mentionnée ci-dessus. Les facteurs à l'origine de la croissance de ce marché sont les marchés émergents et les investissements massifs dans la recherche et le développement.

L'insomnie est un trouble du sommeil qui se manifeste par des difficultés à dormir ou à rester endormi. Les symptômes sont une faible endurance, une somnolence diurne, une dépression et une irritabilité. Il s'agit d'un trouble très courant qui touche des millions de personnes dans le monde entier. La perturbation du rythme circadien, la douleur chronique, l'hyperthyroïdie , la ménopause, le stress psychologique et d'autres problèmes médicaux contribuent tous à l'insomnie. De plus, l'utilisation excessive de drogues telles que la caféine, l'alcool et la nicotine peut entraîner une insomnie. Divers appareils de diagnostic sont utilisés dans les laboratoires du sommeil pour diagnostiquer ce trouble.

L’augmentation du niveau de stress, la présence de molécules brevetées sur le marché, les médicaments potentiels en cours de développement clinique, l’introduction de dispositifs médicaux technologiquement avancés et la croissance de la population gériatrique sont autant de facteurs qui influencent la croissance du marché des traitements contre l’insomnie. La prise de conscience croissante de l’impact du manque de sommeil sur la vie quotidienne devrait augmenter le taux d’adoption de divers traitements contre l’insomnie, ce qui entraînera une croissance des revenus du marché des traitements contre l’insomnie.

Other factors, such as side effects from certain over-the-counter and prescription medications, arthritis, and excessive use of media devices before bed, are increasing the number of people suffering from insomnia, boosting market growth prospects. Furthermore, the rise in psychological disorders and the ever-increasing noise levels in cities will drive the insomnia treatment market during the forecast period. Furthermore, emerging markets and significant investment in research and development are driving this market's growth.

However, misconceptions about the seriousness of insomnia, as well as patient non-adherence to treatment, are among the factors expected to limit market growth over the forecast period. Dearth of skilled medical professionals and lack of a strong healthcare infrastructure in the backward economies are further derailing the market growth rate

This insomnia market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the insomnia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Insomnia Market Scope and Market Size

The insomnia market is segmented on the basis of therapy type, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of therapy type, the global insomnia market is segmented into non-pharmacological and pharmacological therapy
• Based on drug class, the global insomnia market is segmented into melatonin antagonist, antidepressants, benzodiazepines, non-benzodiazepines and others.
• Route of administration segment for global insomnia market is categorized into oral, parenteral and others.
• On the basis of end-users, the global insomnia market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the global insomnia market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.

Insomnia Market Country Level Analysis

Insomnia market is analysed and market size information is provided by the country, therapy type, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the insomnia market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the global insomnia market and will flourish its dominance over the forecast period because of global leaders in research and development activities, an established approval process framework, an increase in the number of FDA-approved drugs and rise in the patient suffering from mental illness. Asia-Pacific is projected to score the highest growth rate owing to the developing healthcare facilities, a large number of generic manufacturers, and an increase in government initiatives and specialist communities.

The country section of the insomnia market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Insomnia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to insomnia market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the insomnia market in the growth period.

Competitive Landscape and Insomnia Market Share Analysis

Le paysage concurrentiel du marché de l'insomnie fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais cliniques, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises en rapport avec les études de marché mondiales sur l'insomnie.

Certains des principaux acteurs opérant sur le marché de l'insomnie sont Takeda Pharmaceutical Company Limited., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Endo International plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan NV, Novartis AG, Lupin., Cipla Inc., Aurobindo Pharma., Torrent Pharmaceuticals Ltd, Alvogen., Merck Sharp & Dohme Corp., Apotex Inc., Zydus Cadila., Saneca Pharmaceuticals, Unichem Laboratories, Neuland Laboratories Ltd., Divi's Laboratories Limited et HIKAL Ltd. entre autres.

SKU-26988